articleMolecular Cancer TherapeuticsJul 1, 2008BRONZE OA

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

University of Lethbridge · National Center for Toxicological Research · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Many chemotherapy regiments are successfully used to treat breast cancer; however, often breast cancer cells develop drug resistance that usually leads to a relapse and worsening of prognosis. We have shown recently that epigenetic changes such as DNA methylation and histone modifications play an important role in breast cancer cell resistance to chemotherapeutic agents. Another mechanism of gene expression control is mediated via the function of small regulatory RNA, particularly microRNA (miRNA); its role in cancer cell drug resistance still remains unexplored. In the present study, we investigated the role of miRNA in the resistance of human MCF-7 breast adenocarcinoma cells to doxorubicin (DOX). Here, we…

Citation impact

635
total citations
FWCI
14.15
Percentile
100%
References
53
Citations per year

Authors

7

Topics & keywords

Keywords
  • microRNA
  • Cancer research
  • Cancer cell
  • Doxorubicin
  • Breast cancer chemotherapy
  • Cancer
  • Transfection
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding